Search research articles
Contact Us
Filters
Showing results (171-180 of 220) with videos related to
Page
of 22
Sort By:
Osteoarthritis and Cartilage
|
July 31, 1998
Inter-observer reliability of the arthroscopic quantification of chondropathy of the knee
X Ayral, A Gueguen, R W Ike, et al.
Journal of Medicinal Chemistry
|
March 26, 2010
Synthesis and SAR of novel 4-morpholinopyrrolopyrimidine derivatives as potent phosphatidylinositol 3-kinase inhibitors
Zecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Arthritis Research & Therapy
|
July 1, 2009
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia
Thierry Lequerré, Carine Bansard, Olivier Vittecoq, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 2, 2010
Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)
Hwei-Ru Tsou, Gloria MacEwan, Gary Birnberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 10, 2019
An outbreak of leptospirosis among kayakers in Brittany, North-West France, 2016
Yvonnick Guillois, Pascale Bourhy, Florence Ayral, et al.
Neuroscience Letters
|
October 20, 2009
A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease
Geoffroy Laumet, Vincent Petitprez, Adeline Sillaire, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2009
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer
Zecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Journal of Medicinal Chemistry
|
May 23, 2008
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4)
Hwei-Ru Tsou, Mercy Otteng, Tritin Tran, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates
Semiramis Ayral-Kaloustian, Jianxin Gu, Judy Lucas, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 28, 2010
PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor
Aranapakam M Venkatesan, Zecheng Chen, Osvaldo dos Santos, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 220) with videos related to
Sort By:
Page
of 22
Osteoarthritis and Cartilage
|
July 31, 1998
Inter-observer reliability of the arthroscopic quantification of chondropathy of the knee
X Ayral, A Gueguen, R W Ike, et al.
Journal of Medicinal Chemistry
|
March 26, 2010
Synthesis and SAR of novel 4-morpholinopyrrolopyrimidine derivatives as potent phosphatidylinositol 3-kinase inhibitors
Zecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Arthritis Research & Therapy
|
July 1, 2009
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia
Thierry Lequerré, Carine Bansard, Olivier Vittecoq, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 2, 2010
Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)
Hwei-Ru Tsou, Gloria MacEwan, Gary Birnberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 10, 2019
An outbreak of leptospirosis among kayakers in Brittany, North-West France, 2016
Yvonnick Guillois, Pascale Bourhy, Florence Ayral, et al.
Neuroscience Letters
|
October 20, 2009
A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease
Geoffroy Laumet, Vincent Petitprez, Adeline Sillaire, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2009
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer
Zecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Journal of Medicinal Chemistry
|
May 23, 2008
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4)
Hwei-Ru Tsou, Mercy Otteng, Tritin Tran, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates
Semiramis Ayral-Kaloustian, Jianxin Gu, Judy Lucas, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 28, 2010
PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor
Aranapakam M Venkatesan, Zecheng Chen, Osvaldo dos Santos, et al.
Page
of 22